Swiss drugmaker Novartis is slashing 2,000 jobs, 1.7 per cent of its workforce, in Switzerland and the United States as it seeks to make annual savings of more than $200 million in the face of growing price pressures and the strong Swiss franc. Novartis's third-quarter core earnings per share rose to $1.45. - (Reuters)